• 091-0612-2631121
  • ao.rmrip@icmr.gov.in

Important Notification: 1. Corrigendum for Walk-in-Interview on 28th to 30th November, 2023. 2. NOTICE FOR CANDIDATES APPLIED FOR THE TECHNICAL CADRE POSTS (Adv No:RMRIMS/Tech/01/2023) 3. Walk in Interview for Junior Research Fellow 4. Walk in Written Test / Interview for various Post,TB Elimination Project : 08.11.2023 & 09.11.2023 5. SYLLABUS & BLUEPRINT FOR CBT OF TECHNICAL CADRE POST 6. LIST OF ELIGIBLE AND NON-ELIGIBLE CANDIDATES FOR THE TECHNICAL CADRE POST OF THE ICMR-RMRIMS,PATNA 7. Flase information in social media regarding recruitment in ICMR-RMRIMS 8. Important Notice for the Advertisements for the Technical Cadre Post 9. Corrigendum Regarding Vacancy Notification     10. #परीक्षा पे चर्चा - 2023


  • Rajendra Memorial Research Institute of Medical Sciences (RMRI), Agamkuan, Patna is one of the Institutes of Indian Council of Medical Research, New Delhi an autonomous body of Ministry of Health and Family Welfare, Govt. of India. The institute is located in the eastern part of the city Patna. The institute has an area of nine acre of land with research wing, administrative wing and residential quarters for the staff. Its main thrust is research in different aspects of Visceral Leishmaniasis like Clinical, Vector biology and control, Immunological, Biochemical, Molecular biology, Pathological, Parasitological and Social. The institute is named after the memory of the first president of Republic of India, Dr. Rajendra Prasad.

    Read More

Dr. Krishna Pandey, Director ICMR-RMRIMS

M.B.B.S, M.D. (General Medicine)

Director Desk

Over last four decades, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna has been primarily instrumental in strengthening national kala-azar elimination programme (NKAEP) through multi-disciplinary research support. We have made commendable progress towards elimination of visceral leishmaniasis (VL) , commonly known as kala-azar, at regional and national levels. Successfully conduted clinical drug trials viz. miltefosine, paromomycin, liposomal amphotericin-B, fungisome, amphomul and combination therapy for VL, PKDL and VL-HIV coinfection, and pharmacovigilance of the antileishmanial drugs have strengthened the treatment strategies under elimination program. India has entered into the elimination phase of VL and with sustained support of all stakeholders we shall soon achieve VL elimination. ICMR-RMRIMS, Patna has been a referral centre for diagnosis and clinical management of visceral leishmaniasis (VL), post-kala-azar dermal leishmaniasis (PKDL) and VL-HIV coinfection.

Read More

Total Samples Tested
Total Positives
Tested on 30.07.2023
Positives on 30.07.2023

Our Collaborators